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Bringing rheumatology research to the next level: addressing the main challenges of patient partnerships in research and health care service design Background: Online technology has revolutionised the way in which people connect and share their experiences. It also brings new opportunities to engage patients in health and social care research through the use of an online research community platform (ORCP). For example, it can improve the accuracy and usefulness of information gathered about research priorities, and it can be used to understand behaviours and preferences. Given an increasing prevalence of long-term conditions including rheumatoid arthritis, online technology represents a novel route for participation and engagement in research. Objectives: To explore the benefits and limitations of an ORCP through understanding lived experiences of adults with rheumatoid arthritis. Methods: We used a purposive sampling approach to ensure variation of key attributes amongst people with rheumatoid arthritis. A total of eight individuals used the ORCP during the pilot study. Qualitative data were collected through online focus groups, conducted as semi-structured interviews and asynchronous threaded discussions. The study was conducted in line with fieldwork guidelines, and written informed consent was obtained.
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Results:
The closed ORCP enabled a physically disconnected group to share their experiences of living with rheumatoid arthritis, describing the symptoms, diagnostic experience and support they received. In addition, participants shared their experiences and opinions about treatment delivery and adherence, the impact of rheumatoid arthritis, and the experiences of transitional care from paediatric to adult health services, where appropriate. Reasons and feeling about research participants and drug development processes were also discussed. Conclusions: Our pilot study provided important accounts from people living with rheumatoid arthritis, highlighting the substantial impact of the disease on their daily lives. The ORCP removed physical contact between the researcher and participants, the absence of which may enable a richer data collection. However, it also has its limitations, primarily because the researcher is less able to gauge participants' attitudes and concerns. ORCPs represent a novel route of data collection, enabling researchers to immerse themselves into a community of individuals, whether they be patients, carers or professionals. Acknowledgements: The authors would like to thank the individuals who contributed their thoughts and experiences to the pilot study. Objectives: The aim of the project was to create a training course for Germanspeaking patient representatives and thereby to invigorate the principle of participatory research in Germany. The training course is supposed to enable patients to make valuable contributions in research projects. In addition the training course aimed at lowering barriers and strengthening the patients' selfconfidence, in order to facilitate their integration in the unfamiliar environment among researchers. Methods: Participants were trained during a two-day interactive training course. For evaluation of the course, each participant anonymously answered 14 questions in a questionnaire.
The training course consists of seven modules. In the first module (I), the history of the EULAR "patient research partners" is described and the tasks of the future German patient research partners are outlined. In the following modules, various types of research and study designs (II), the generation of research questions and hypotheses (III), various scientific tools (IV), the detailed sequence of steps in a typical research project (V), literature research in scientific databases (VI) and the process of reviewing grant applications (VII) are explained. Each module is subdivided in an explanatory section, an exercise section (where the participants have to apply the newly achieved skills) and a final discussion section. So far, two courses have been conducted. The training course was rated either "very good" or "good" by 77% and 23% of the participants, respectively. Those patients, already actively involved in research projects, acclaim participatory research as interesting and enriching. Conclusions: The training course was perceived very well by the participants. In future follow-up meetings, the usefulness of the various modules and any missing items will be discussed and the training course adapted accordingly. Acknowledgements: We thank Dr. C. Sander for her contribution to the training course. Background: The design of clinical trials for osteoarthritis is challenging; structural changes in tissues are quantitatively small and proceed very slowly. No clear guidance exists on how to optimise recruitment. KL grade is a poor recruitment criterion as centres interpret KL differently. Quantitative measures should be better, and metric radiographic joint space width (rJSW) is related to subsequent risk of radiographic progression. Although new MRI measures provide increased responsiveness in DMOAD trials, it is unknown whether selecting for recruitment based on radiographic criteria are well suited for responsiveness of these new measures. Objectives: (1) To determine which baseline rJSW values are associated with most subsequent progression for rJSW, MRI cartilage and bone outcomes (2) Explore baseline covariates that influence progression rates (3) Estimate the trial numbers needed using the criteria determined by steps (1) and (2). Methods: We used all knees from the Osteoarthritis Initiative which had all 3 measures recorded (rJSW -Duryea method; MRI cartilage thickness & bone area, Imorphics) at baseline, 1 and 2 years. We categorised knees into bins of 1mm rJSW, and assessed the 2 year changes of each bin, and characterised the distribution of rJSW in KL 0 knees. We used ANCOVA models to consider which covariates (including gender, height, weight, alignment, age, pain severity) affected 2-year slope of change, and responsiveness using SRM. For the final optimised recruitment groups, we calculated SRMs (CIs assessed using the bootstrap method of Efron) and derived the number of patients per arm in a putative trial. Results: 4796 knees were included (2789 females, mean age 61.45). The lower 95th percentile values for rJSW in women and men were 3.9 and 4.5mm respectively. The mean changes at 2-years for all 3 outcomes were greatest for the categories of 2-3 and 3-4mm baseline rJSW ( Figure 1A Figure 1B shows the relative SRMs for the 3 outcomes based on 2 inclusion criteria (rJSW 2-4mm and pain ≥3/20; n=331) and demonstrates the required trial numbers (with confidence intervals) based on the SRMs.
Conclusions:
Selecting patients based on 2 simple criteria will improve responsiveness in clinical trials for all 3 imaging outcomes using standard imaging outcomes. Selecting for rJSW of 2-4mm is most important while adding a pain criteria further improves responsiveness; no other covariates improved this. Caution should be applied when using SRM to power a study because of the inherent difficulties in calculating standard deviations; Fig 1B shows for example that the confidence limits for rJSW at 12 months vary from 302 to 1489. This analysis also confirms the advantages of MRI outcomes over rJSW in terms of study size and duration: a 12-month study with cartilage thickness or bone area endpoints needs no more than 238 or 137 patients (including the upper 95th percentile confidence limit). 
